Antidepressant found to reduce COVID-19 hospitalizations: study

An affordable antidepressant has been found in a clinical trial to reduce the risk of hospitalization in high-risk adults with recently-diagnosed COVID-19, according to a study published in The Lancet Global Health.The drug, known as fluvoxamine is…